[ad_1]
▲ Jung Eun-kyung, head of the Central Defense Countermeasures Headquarters (Director of Disease Control), is giving a regular briefing at the Centers for Disease Control in Cheongju City, Chungbuk, on the afternoon of 14, including the national Corona 19 outbreak and the results of interim investigations of confirmed patients. Commissioner Chung returned to the scene after receiving hospital treatment for a broken shoulder earlier this month and attended the briefing in about two weeks. | |
Ⓒ Yonhap News |
See related photos |
He said the government has secured a total of 56 million new vaccines against coronavirus infection (Corona 19) until recently, and that the introduction of additional quantities is not yet being considered.
Jung Eun-kyung, head of the Central Defense Countermeasures Headquarters (Bang Dae-bon), said in a regular briefing on the 31st, “We are not reviewing the amount of additional vaccines in addition to the amount insured so far.”
“We continue to review the vaccine platforms and products of various companies,” Jung said, but emphasized that “the current number of around 56 million people has been confirmed.”
He said that “in relation to the immunological effect of the vaccine, it is necessary to take into account the duration of the vaccine and the need for additional or regular vaccines, and continually complement the strategies for the introduction of the vaccine and the development of the national vaccine” , said.
Jung explained that he is currently reviewing a purchase contract with the American pharmaceutical company ‘Modena’.
Earlier, the Blue House announced that President Moon Jae-in had agreed to supply 20 million Corona 19 vaccines to South Korea by Modena in a phone call with Modena CEO Stefan Bancel on the 28th.
Regarding the progress of the contract with Modena, Jung said: “We continue to review and negotiate the contract (for the purchase of vaccines)” and “there was progress in most of the negotiations.”
Regarding the contract, the Blue House announced ‘agreement’ and the Modena side was ‘debating’, respectively, indicating that there was controversy. “The situation has agreed to some extent the expansion of the initial 20 million doses to 40 million doses.” did.
He added that “the contract is resolved only when the contract is reviewed and the contract is signed,” he added. “The situation continues to discuss the contract.”
Headquarters Jung said negotiations are continuing so that the vaccine for 10 million people insured through the COVAX facility, an international project for the joint purchase and distribution of vaccines, can be introduced in the first quarter of next year.
“We signed the agreement on October 9 and paid the advance,” he said. “We are currently negotiating the amount that can be supplied through the Global Association for Vaccine Immunity (GAVI) in the first quarter,” he said.
He added that “the consultation is ongoing on the specific quantity and delivery time,” he said. “Because the decision must be made through coordination with several countries participating in COVAX, we are negotiating to receive it quickly in the first quarter.”
Regarding the vaccine purchase budget, he said, “a budget of less than 400 billion won is reflected in this year’s budget, and around 900 billion won is reflected as a reserve for next year, and they insure about 1.3 trillion won. ” It has already been paid in the form of an advance, ”he said.
He added: “There is a budget for the interim payment and the balance. We plan to secure the insufficient budget or additional budgets related to vaccination in the form of reserve funds,” he explained that detailed discussions are taking place.
General manager Jung promised to prepare thoroughly so as not to interfere with the vaccination.
He said: “The safety and efficacy aspects of vaccines are very important than other treatments,” he said. “Since many countries have started and are in the process of vaccination, we are gathering information on safety and efficacy as much as possible and preparing vaccination plans.”
<저작권자(c) 연합뉴스, 무단 전재-재배포 금지>